{"id":"W2242358350","doi":"10.1200/jco.2005.23.16_suppl.3085","title":"A phase I study of a second generation antisense oligonucleotide to clusterin (OGX-011) in combination with docetaxel: NCIC CTG IND.154","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Clusterin; Docetaxel; Medicine; Toxicity; Internal medicine; Peripheral blood mononuclear cell; Phases of clinical research; Oncology; Chemotherapy; Apoptosis; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006348478,0.00162111,0.001408107,0.0005687361,0.0005764996,0.0007765264,0.001171116,0.001202926,0.003915374],"category_scores_gemma":[0.0003447891,0.0005481003,0.0006820633,0.000379445,0.0009294169,0.0004699362,0.0002998747,0.002552094,0.0008252851],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001673477,"about_ca_system_score_gemma":0.003136541,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006698566,"about_ca_topic_score_gemma":0.01618762,"domain_scores_codex":[0.9997451,0.00006316349,0.00001175649,0.00006241404,0.00003488619,0.00008265979],"domain_scores_gemma":[0.9996519,0.00003717844,0.00004864263,0.00002844199,0.00002572825,0.000208132],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4211077,0.238354,0.00767438,0.001174507,0.0009142063,0.000735877,0.0006883997,0.004036613,0.193586,0.0006934014,0.008936968,0.122098],"study_design_scores_gemma":[0.2501545,0.7218683,0.008399736,0.00003158175,0.0002608709,0.0003418174,0.0000871669,0.0009883754,0.01289211,0.00009478233,0.004854047,0.00002680499],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9915252,0.0007827591,0.0005192923,0.0003093554,0.0001205099,0.003818534,0.0008772186,0.00009623039,0.001950813],"genre_scores_gemma":[0.9815817,0.001433444,0.001905019,0.0006441554,0.0001285401,0.004760965,0.002479463,0.00003414576,0.00703251],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006698566,"threshold_uncertainty_score":0.01331919,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1374390763065841,"score_gpt":0.4899005935502139,"score_spread":0.3524615172436298,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}